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Outcomes and Indications for Thoracofemoral Bypass in the Endovascular Age: A case series 
and Literature Review 
 
Andrea McSweeney, Babak Abai, MD* 
 
Introduction: Endovascular revascularization is commonplace in vascular surgery; 
however, thoracofemoral bypass (TFB) is optimal in particular patients. Little research focuses 
on TFB outcomes. This case series and literature review investigated indications, efficacy, and 
safety of TFB.  
 
Methods: Cases at Thomas Jefferson University Hospital (TJUH) included one male and four 
females (average age 57.2) from 2015-2019. Literature review yielded 124 cases from other 
institutions. PubMed and Scopus search using the term “thoraco femoral bypass” yielded 39 
articles. Articles published before 2000 and case studies published in any year were excluded. 
Seven articles were selected. Primary outcomes included 30-day mortality and graft patency; 
secondary outcomes included complications and indications. Data was tabulated in tables and 
percentages were calculated. 
 
Results: One hundred and twenty-nine cases of TFB were identified. Some indications included 
revascularization of failed aortobifemoral bypass (31.8% of patients) and circumferential aortic 
calcification with or without concomitant infrarenal or mesenteric calcification (20.1%). Thirty-
day mortality for all cases was 4.7%. Thirty-day mortality for TJUH patients was 0%. Graft 
patency for TJUH patients was 100% at six months. At publication, three of five patients had 
been revascularized for over one year and had patent grafts at one year. Some complications 
included pulmonary (12.5% of patients), major vascular reintervention (7.8% of patients) and 
incision site infection (4.1% of patients).  
 
Discussion: In recent years, few institutions have reported TFB outcomes. High graft patency 
and low 30-day mortality at TJUH and other institutions emphasize the safety and efficacy of 
TFB. 
 
 
